The impact of exacerbation frequency on mortality following acute exacerbations of COPD: A registry-based cohort study

BMJ Open

Volumn 4, Issue 12, 2014, Pages 1-7

  Schmidt, Sigrun Alba Johannesdottir ^a   Johansen, Martin Berg ^a   Olsen, Morten ^a   Xu, Xiao ^b   Parker, Joseph M ^c   Molfino, Nestor A ^d   Lash, Timothy L ^a,e   Sorensen, Henrik Toft ^a   Christiansen, Christian Fynbo ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ASTRAZENECA   (United Kingdom)

^c MEDIMMUNE   (United States)

^d KaloBios Inc   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; GENERAL PRACTICE; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; OUTPATIENT CARE; VERY ELDERLY; ACUTE DISEASE; DENMARK; DISEASE COURSE; EPIDEMIOLOGY; REGISTER; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DENMARK; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; REGRESSION ANALYSIS;

EID: 84920778363     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006720     Document Type: Article

References (27)

1. Donaldson GC, Wedzicha JA. COPD exacerbations.1: Epidemiology. Thorax 2006;61:164-8.
2. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012;379:1341-51.
3. Lash TL, Johansen MB, Christensen S, et al. Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study. Lung 2010;189:27-35.
4. Juel K, Drossing M. [Chronic obstructive pulmonary disease]. Public Health Report, Denmark, 2007.
5. From the Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (updated 2013). http://www.goldcopd.org/ (accessed 28 Apr 2013).
6. Hoogendoorn M, Feenstra TL, Hoogenveen RT, et al. Association between lung function and exacerbation frequency in patients with COPD. COPD 2010;5:435-44.
7. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
8. Seemungal TAR, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD - a review of potential interventions. COPD 2009;4:203-23.
9. Wedzicha JA, Brill SE, Allinson JP, et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med 2013;11:181.
10. Almagro P, Cabrera FJ, Diez J, et al. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 2012;142:1126-33.
11. Almagro P, Calbo E, Ochoa de Echagüen A, et al. Mortality after hospitalization for COPD. Chest 2002;121:1441-8.
12. Dransfield MT, Rowe SM, Johnson JE, et al. Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008;63:301-5.
13. Faustini A, Marino C, D'Ippoliti D, et al. The impact on risk-factor analysis of different mortality outcomes in COPD patients. Eur Respir J 2008;32:629-36.
14. Kim S, Clark S, Camargo CA Jr. Mortality after an emergency department visit for exacerbation of chronic obstructive pulmonary disease. COPD 2006;3:75-81.
15. McGhan R, Radcliff T, Fish R, et al. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007;132:1748-55.
16. Roche N, Zureik M, Soussan D, et al. Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J 2008;32:953-61.
17. Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012;67:957-63.
18. Piquet J, Chavaillon JM, David P, et al. High-risk patients following hospitalisation for an acute exacerbation of COPD. Eur Respir J 2013;42:946-55.
19. Gudmundsson G, Gislason T, Lindberg E, et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006;7:109.
20. Schmidt M, Pedersen L, Sorensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol 2014;29:541-9.
21. Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health 2011;39:30-3.
22. Ehrenstein V, Antonsen S, Pedersen L. Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol 2010;2:273-9.
23. Johannesdottir SA, Christiansen CF, Johansen MB, et al. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. J Med Econ 2013;16:897-906.
24. Littner MR. In the clinic. Chronic obstructive pulmonary disease. Ann Intern Med 2011;154:ITC4-1-15; quiz ITC4-16.
25. Thomsen RW, Lange P, Hellquist B, et al. Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med 2011;105:1063-8.
26. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J 2003;21:46s-53s.
27. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 2009;20:488-95.